Boehringer outlines next step in $382M expansion

Boehringer Ingelheim has submitted the blueprints for two new buildings on its Connecticut campus, part of its $382 million expansion plan first laid out in 2007. The 60,000 square feet of added space includes a support building for the process development laboratory as well as a new facility for "pilot scale pharmaceutical development equipment and the airlocks associated with these equipment rooms." Report

Suggested Articles

Quench Bio is going after a family of proteins involved in inflammatory cell death to treat inflammatory diseases in a more holistic way.

What a difference a day makes in biotech.

A report out this week by PwC thinks that biotech could be in for a good year for deals as it sees the momentum from 2019 growing.